HSPH1 and lymphoma: In this study, we used a silencing approach to investigate the role of HSP110 and showed for the first time that it plays a key role in the survival of PEL cells, an aggressive KSHV-associated lymphoma, characterized by a poor response to conventional chemotherapies [27].